Analysts Have Lowered Expectations For Precision BioSciences, Inc. (NASDAQ:DTIL) After Its Latest Results

Precision BioSciences, Inc. (NASDAQ:DTIL) recently released a disappointing second-quarter report with revenues significantly lower than predicted and increased per-share losses. Analysts have subsequently cut next year's revenue estimates and raised loss per share forecasts, indicating a change in sentiment. Despite this, the consensus price target remains unchanged, though there's a wide range in individual analyst valuations.